← Back to headlines
New Pancreatic Cancer Pill Shows Promise in Early Trials
Early trial results for a new daily pill, daraxonrasib, are showing significant promise in treating advanced pancreatic cancer in patients with RAS mutations.
18 May, 11:00 — 18 May, 11:00
Related Stories
Scientists Discover Largest Ancient Scorpion, Size of a Dog
just now
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Magnetic Field of Galaxy Cluster Mapped for the First Time
39m ago
Net-Casting Spiders' Unique Hunting Method Inspires Engineers
2h ago